Catalyst

Slingshot members are tracking this event:

Pain Therapeutics (PTIE) Announces Plans for Resubmission of NDA to FDA for Pain Medication REMOXY ER

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PTIE

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 21, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Resubmission, Nda, Pain Medication, Remoxy Er, New Drug Application